Evaluating efficacy and safety of ocrelizumab biosimilar (Xacrel) compared to the originator (Ocrevus) in relapsing multiple sclerosis: a phase III, randomized, equivalency, clinical trial
评估奥克瑞珠单抗生物类似药(Xacrel)与原研药(Ocrevus)在复发型多发性硬化症中的疗效和安全性:一项III期随机等效性临床试验
期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-024-75745-y
Sahraian, Mohammad Ali; Abolfazli, Roya; Shaygannejad, Vahid; Ashtari, Fereshteh; Majdinasab, Nastaran; Navardi, Samira; Baghbanian, Seyed Mohammad; Sedighi, Behnaz; Naser Moghadasi, Abdorreza; Nahayati, Mohammad Ali; Ghalyanchi Langroodi, Hamidreza; Mohammadianinejad, Seyed Ehsan; Beladi Moghadam, Nahid; Ayromlou, Hormoz; Nikseresht, Alireza; Ghiasian, Masoud; Razazian, Nazanin; Asadollahzadeh, Elnaz; Sabzvari, Araz; Kafi, Hamidreza; Albooyeh, Sogol